| Clinical Pharmacy Practice Guidelines |
|
|
|
A new set of Clinical Pharmacy Guidelines on Management of Chronic Heart Failure has been released in Oct 2007. The objectives of these guidelines are to provide an up-to-date and practical approach for the management of a patient with chronic heart failure and to assist pharmacists in the pharmacological and non-pharmacological management of chronic heart failure patients. These guidelines will support pharmacists practising in heart failure clinics in an outpatient setting, titrating mainly angiotensin converting enzyme inhibitors, angiotensin II receptor blockers and beta-blockers to target doses after these have been first prescribed by a physician. It can also be used by other healthcare professionals concerned with the care of patients with chronic heart failure. For these and an earlier guideline on Anticoagulation- Warfarin, please refer MOH Health Professionals Portal. Comments (2)
Asoka .Wettasinghe: ...
Before prescribing this medicine, it is necessary to under go full clinical examination especially kidney funtions test & lipid profile test.
1
January 19, 2008
Asoka .Wettasinghe: side effects of angiotensin converting enzymes
Please let me know the majour side effects of angiotenis converting enzymes in long term prescription. Also to over come these side effects with other alternative medicaments available at present.
2
January 19, 2008
Write comment
You must be logged in to a comment. Please register if you do not have an account yet.
|
| < Prev | Next > |
|---|